Physician profile
David C Perry
NPI 1508802323
$4,534.36
in general payments reported to CMS, 2019-2025
16 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,472 · 2020: $109 · 2021: $423 · 2022: $890 · 2023: $1,285 · 2024: $245 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230 · Travel and Lodging: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.36 |
| Travel and Lodging | $410.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,172.80 | 2019-2025 | Journey II, Real Intelligence, Legion Revision |
| Depuy Synthes Sales INC. | $517.80 | 2019-2022 | |
| Carlsmed, INC. | $387.85 | 2023 | Aprevo |
| Wright Medical Technology, INC. | $79.37 | 2019 | |
| Bioventus LLC | $60.48 | 2019-2023 | Supartz Fx Sodium Hyaluronate, L360 Thigh System |
| Pacira Therapeutics, INC. | $56.19 | 2019-2020 | |
| Kerecis Limited | $51.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $40.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $35.37 | 2022-2024 | Zilretta, Iovera, Exparel |
| Ferring Pharmaceuticals INC. | $27.03 | 2021 | |
| Heraeus Medical, LLC. | $25.39 | 2021-2025 | |
| Organogenesis INC. | $18.23 | 2022 | |
| Sonex Health, INC. | $17.98 | 2021 | |
| Djo, LLC | $15.27 | 2021 | |
| Si-Bone, INC. | $14.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $13.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.